Merck & Co. Inc. buy Argus
Start price
07.06.24
/
50%
€119.60
Target price
07.06.25
-
Performance (%)
-42.31%
End price
08.06.25
€69.00
Summary
This prediction ended on 08.06.25 with a price of €69.00. Massive losses of -42.31% were the result for the BUY prediction by Argus. Argus has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. A total of €2.99 was paid as dividends for this prediction. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 8.621% | 8.621% | 75.736% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by Argus for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at Argus to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten